Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
BABA-W
09988
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | 1.76%471.47M | 10.35%951.53M | 18.57%463.33M | 21.99%862.25M | 18.11%390.76M | 19.06%706.82M | --330.83M | 24.45%593.66M | --477.04M |
| Operating income | 1.76%471.47M | 10.35%951.53M | 18.57%463.33M | 21.99%862.25M | 18.11%390.76M | 19.06%706.82M | 330.83M | 24.45%593.66M | 477.04M |
| Cost of sales | 0.38%-392.17M | -8.61%-808.31M | -17.50%-393.69M | -22.84%-744.21M | -18.41%-335.04M | -19.39%-605.82M | ---282.95M | -23.01%-507.43M | ---412.52M |
| Operating expenses | 0.38%-392.17M | -8.61%-808.31M | -17.50%-393.69M | -22.84%-744.21M | -18.41%-335.04M | -19.39%-605.82M | -282.95M | -23.01%-507.43M | -412.52M |
| Gross profit | 13.87%79.3M | 21.34%143.22M | 25.00%69.65M | 16.87%118.04M | 16.36%55.71M | 17.13%101M | 47.88M | 33.65%86.23M | 64.51M |
| Administrative expenses | -10.03%-32.13M | -22.50%-65.09M | -18.08%-29.21M | -6.41%-53.14M | -0.35%-24.73M | -2.50%-49.94M | ---24.65M | -22.76%-48.72M | ---39.69M |
| Research and development expenses | -238.60%-728K | -145.55%-469K | ---215K | ---191K | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | -41.66%-3.77M | -193.57%-11.36M | -311.44%-2.66M | 25.37%-3.87M | 88.49%-647K | -346.39%-5.19M | ---5.62M | -340.58%-1.16M | --483K |
| -Other impairment is provision | -41.66%-3.77M | -193.57%-11.36M | -311.44%-2.66M | 25.37%-3.87M | 88.49%-647K | -346.39%-5.19M | ---5.62M | -340.58%-1.16M | --483K |
| Special items of operating profit | 1.71%1.25M | 122.57%8.53M | 22.98%1.23M | -10.46%3.83M | -52.31%1M | -21.26%4.28M | --2.1M | -67.43%5.44M | --16.69M |
| Operating profit | 13.22%43.92M | 15.70%74.83M | 23.80%38.79M | 28.94%64.67M | 58.98%31.33M | 20.04%50.15M | 19.71M | -0.53%41.78M | 42M |
| Financing cost | -208.06%-1.95M | 70.39%-443K | 9.05%-633K | 14.76%-1.5M | 8.66%-696K | 39.34%-1.76M | ---762K | 65.46%-2.89M | ---8.38M |
| Earning before tax | 9.99%41.97M | 17.74%74.38M | 24.55%38.16M | 30.53%63.17M | 61.70%30.64M | 24.46%48.4M | 18.95M | 15.64%38.89M | 33.63M |
| Tax | -37.95%-9.87M | -9.33%-13.29M | -32.00%-7.16M | -10.91%-12.16M | -70.61%-5.42M | -41.75%-10.96M | ---3.18M | -10.54%-7.73M | ---7M |
| After-tax profit from continuing operations | 3.53%32.1M | 19.75%61.09M | 22.95%31M | 36.27%51.02M | 59.90%25.22M | 20.17%37.44M | 15.77M | 16.98%31.16M | 26.63M |
| Earning after tax | 3.53%32.1M | 19.75%61.09M | 22.95%31M | 36.27%51.02M | 59.90%25.22M | 20.17%37.44M | 15.77M | 16.98%31.16M | 26.63M |
| Minority profit | -6.54%1.24M | 59.52%2.06M | 168.69%1.33M | 2,183.87%1.29M | 214.32%495K | 93.99%-62K | ---433K | ---1.03M | ---- |
| Profit attributable to shareholders | 3.98%30.86M | 18.71%59.03M | 20.03%29.67M | 32.60%49.73M | 52.57%24.72M | 16.51%37.5M | 16.2M | 20.86%32.19M | 26.63M |
| Basic earnings per share | -22.03%0.46 | 2.02%1.01 | 20.41%0.59 | 24.84%0.99 | 34.25%0.49 | 5.17%0.793 | 0.365 | 21.03%0.754 | 0.623 |
| Diluted earnings per share | -22.03%0.46 | 2.02%1.01 | 20.41%0.59 | 24.84%0.99 | 34.25%0.49 | 5.17%0.793 | 0.365 | 21.03%0.754 | 0.623 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | KPMG, Sigma (Special General Partnership) | -- | KPMG, Sigma (Special General Partnership) | -- | KPMG, Sigma (Special General Partnership) | -- | PwC, Sigma Accounting Firm (Special General Partnership) | PwC, Sigma Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.